Bookmark and Share

Compound Summary for: CID 37632     Try the new version summary page

adinazolam

Also known as: Adinazolamum; Deracyn; Adinazolamum [INN-Latin]; Adinazolam [USAN]; CHEBI:251412; UNII-KN08449444; Adinazolam (USAN/INN); AC1L1Y4K
Molecular Formula: C19H18ClN5   Molecular Weight: 351.83272   InChIKey: GJSLOMWRLALDCT-UHFFFAOYSA-N
Adinazolam (Deracyn®) is a benzodiazepine derivative. It possesses anxiolytic, anticonvulsant, sedative, and antidepressant properties. Adinazolam was developed by Dr. Jackson B. Hester, who was seeking to enhance the antidepressant properties of alprazolam, which he also developed. Adinazolam was never FDA approved and was never available to the public.    From: DrugBank
Show subcontent titlesTable of Contents
Identification
Related Records
show first sub-section only
Pharmacology
Literature
Patents
Biomolecular Interactions and Pathways
Biological Test Results
Classification
Chemical and Physical Properties
_ _